Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Myopia: later-stage trial registry
22 of 91 indexed Myopia trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #151 of 28,707 conditions by registered trial count.
91 US clinical trials · 22 currently recruiting · #151 of 28,707 conditions by registered trial count
Myopia: 91 US clinical trials tracked, 22 recruiting.
Myopia is the subject of 91 registered US clinical trials on ClinicalTrials.gov, 22 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is CooperVision, running 13 of these trials.
Enrollment posture brief
Registry condition myopia
OPEN 22 | RECR 24% | LATE 4 | EARLY 2 | RANK #151 | SPON 13
Volume-matched condition peers
Nearest open-share peer: HIV/AIDS (24% recruiting · 62 trials)
Myopia lists 22 open slots (24% of 91 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Myopia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Myopia is recruiting below its size-band peers.
22 of 91 indexed trials (24.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Myopia trials is spread across many organizations.
CooperVision accounts for 13 of 91 trials (14.3%). 44 distinct sponsors appear on at least one study for this condition label.
-
Typical Myopia enrolment sits around 80 participants.
Median target enrolment is 80 among the 91 trials that report a genuine target (sentinel values excluded). 51 of those (56%) plan for fewer than 100 participants.
-
Myopia research is mostly interventional.
78 interventional and 13 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
91 total, page 2 of 2
Safety and Efficacy of a Contact Lens for Daily Disposable Use
Bausch & Lomb Incorporated
NCT01365039
Myopia Control With a Innovative Spectacle Lens
Essilor International
NCT05174780
DAILIES TOTAL1 Versus ACUVUE TruEye - Effects on the Biology of the Ocular Surface and Lid Margin
University of Texas Southwestern Medical Center
NCT02347631
A Multi-Center Investigation of Patient Acceptability of OPTI-FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)
Alcon Research
NCT00772707
Clinical Performance of Two Commercial, Daily Disposable Contact Lenses
Alcon Research
NCT05010512
Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care Systems
Alcon Research
NCT01699750
Air Optix Night and Day Aqua (AONDA) Retrospective Study 1
Alcon Research
NCT05790928
DD T2 Daily Disposable Registration Trial
Alcon Research
NCT03305770
A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens
Bausch & Lomb Incorporated
NCT01412983
Clinical Evaluation of Stenfilcon A Soft Contact Lens When Compared to Ocufilcon B Soft Contact Lens
CooperVision
NCT01354223
Multi-Center Clinical Evaluation of Two Reusable Soft Contact Lenses
CooperVision
NCT02542072
Study of Theories About Myopia Progression (STAMP)
Ohio State University
NCT00335049
Comparison of Two Daily Disposable Lenses
Alcon Research
NCT04013789
Clinical Evaluation of Reusable Soft Contact Lenses
CooperVision International Limited (CVIL)
NCT06119191
Performance Evaluation of Daily Disposable Contact Lenses in Habitual Lens Wearers Who Use Digital Devices Frequently
CooperVision
NCT05805150
A Study to Evaluate a New Silicone Hydrogel Contact Lens
Bausch & Lomb Incorporated
NCT01309893
Evaluation of a New Silicone Hydrogel Contact Lens
Bausch & Lomb Incorporated
NCT01309880
Clinical Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens
Alcon Research
NCT04476784
Performance Comparison Between Fanfilcon A and Senofilcon A Sphere Lenses
CooperVision
NCT02956460
A Study to Evaluate the Product Performance of the PureVision®2 High Definition (HD) Contact Lens
Bausch & Lomb Incorporated
NCT01416142
An Outcomes Study Comparing the Intralase FS 60 to the Intralase iFS When Performing LASIK Surgery for Nearsightedness
Stanford University
NCT01365728
A Dispensing Clinical Trial of Test Contact Lens Against Marketed Contact Lens
CooperVision
NCT03499067
Performance Evaluation of Reusable Contact Lenses When Worn For One Month By Habitual Soft Contact Lens Wearers
CooperVision
NCT06098339
A Dispensing Comparison of a Test Daily 1 Day Lens Against a Control 1 Day Lens.
CooperVision
NCT03951610
Effect of Preoperative Pupil Size on Quality of Vision After Wavefront-Guided LASIK
Stanford University
NCT00889941
IntraLase vs Hansatome Flaps in LASIK
Stanford University
NCT00691431
Patient Satisfaction With Contoura Vision Topography-Guided LASIK
Rush Eye Associates
NCT04903301
Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software
Mann Eye Institute
NCT05848817
Apioc Contact Lens Feasibility
Lentechs
NCT03688672
A Prospective Evaluation of Contrast Sensitivity and Disability Glare in Refractive Surgery, a Sub-Study of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99)
Walter Reed Army Medical Center
NCT00413868
Vistakon Investigational Lens Worn as a Single Use Daily Wear
Johnson & Johnson Vision Care
NCT01031004
Quality of Vision and Quality of Life With LASIK
Edward E. Manche
NCT02161263
A One-Week Crossover Dispensing Evaluation of New Daily Wear Soft Contact Lenses
CooperVision
NCT03306641
Comparison of Conventional and Custom Photorefractive Keratectomy (PRK)
University of Utah
NCT00713856
Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control
University of Florida
NCT05477875
Clinical Validation of the Apollo Daily Disposable Soft Contact Lenses
CooperVision
NCT05035017
The Influence of Atropine on Choroidal Thickness
State University of New York College of Optometry
NCT03158142
A 6-Hour Clinical Evaluation of New Daily-Wear Soft Contact Lenses
CooperVision
NCT03235089
Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy
Virdi Eye Clinic
NCT01475877
A Contralateral Dispensing Clinical Trial of Study Test Sapphire Lens Against Enfilcon A Silicone Hydrogel Lens
CooperVision
NCT02518490
Dynamic Change in Accommodation After Wearing Multifocal Soft Contact Lenses for Myopia Control
State University of New York College of Optometry
NCT04763694
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Myopia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Myopia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Myopia page
91 registered trials, 22 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 22 Myopia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- CooperVision sponsors the most Myopia trials on record, review their full trial history before evaluating a specific study. See CooperVision's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Myopia condition card totals 91 registered trials; most-linked intervention senofilcon A; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.